Bin Qiao

3PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 09, 2026
A phase II trial of chemotherapy-free neoadjuvant camrelizumab plus apatinib for resectable HNSCC: pathological response and vascular-immune crosstalk.

|Dec 05, 2019
MUC1 as a target for CAR-T therapy in head and neck squamous cell carinoma.

Zi Mei, Kai Zhang, Alfred King-Yin Lam

Pageof 1